North America Minimally Invasive Devices Market Industry: Market Size & Forecast 2026

North America commands the largest share of the global medical device industry, with the region representing approximately 40% of a worldwide market projected to reach $669.70 billion by 2029. The minimally invasive surgery segment has undergone a fundamental transformation over the past two decades, with laparoscopy and robotic-assisted approaches progressively replacing traditional open surgical methods. Government health databases and insurance claims data confirm expanding adoption across procedure types, though no single comprehensive federal statistical system captures the full scope of this market.

• •North America held a 39% global share of the biomaterials market in 2024, driven largely by demand for minimally invasive surgical procedures
• •The shift from open surgery to minimally invasive techniques has been documented over a 16-year period across numerous surgical specialties
• •Claims and healthcare encounter databases provide the primary mechanism for tracking procedure volumes and market activity in the United States

The primary growth engine for the market is the clinical and economic advantage that minimally invasive procedures offer over open surgery, including reduced hospital stays, lower complication rates, and faster patient recovery. Healthcare economics evaluations indicate that while minimally invasive implants and equipment carry higher upfront costs, the overall economic burden on the healthcare system is favorably offset by shorter hospitalization and quicker return to function. The aging U.S. population and rising prevalence of chronic conditions requiring surgical intervention further sustain demand.

• •Specialized segments such as minimally invasive spinal fusion devices and neurovascular procedures are experiencing some of the highest growth rates within the broader market
• •Regulatory approval pathways overseen by the FDA maintain safety standards while facilitating innovation in device technology
• •Expanding insurance coverage and Medicare reimbursement for minimally invasive procedures continues to drive adoption among healthcare providers

The market spans multiple surgical specialties including general surgery, urology, neurosurgery, cardiology, and orthopedics, each with distinct minimally invasive device requirements. Neurovascular minimally invasive devices represent one of the fastest-growing segments, with certain procedure categories expanding at compound annual growth rates exceeding 50% in recent years. Within North America, the United States constitutes the dominant market due to its advanced hospital infrastructure, concentrated research institutions, and favorable reimbursement environment.

• •Minimally invasive partial nephrectomy and similar urological procedures show measurable growth trends based on national healthcare encounter databases
• •Robotic-assisted surgical systems have emerged as a key technology platform reshaping the competitive dynamics of multiple segments
• •Biomaterials and polymeric implant technologies form a foundational component of the market, supporting device innovation across surgical applications

What are the recent trends and outlook?

Looking forward, the market is positioned for sustained expansion driven by continued clinical evidence demonstrating patient outcomes advantages of minimally invasive approaches. Robotic surgery adoption is expected to deepen beyond its current urological and gynecological strongholds into general surgery, thoracic procedures, and complex reconstructive applications. Emerging innovations in smart instrumentation, enhanced imaging integration, and single-port access platforms are likely to further expand the range of procedures amenable to minimally invasive techniques through the end of the decade.

• •Technological convergence between surgical robotics, artificial intelligence-assisted navigation, and advanced biomaterials is accelerating product development cycles
• •Outpatient and ambulatory surgical center adoption of minimally invasive technologies is expanding as devices become more compact and cost-effective
• •Healthcare cost containment pressures are creating incentives for wider adoption of minimally invasive approaches that reduce overall treatment expenses despite higher device costs